Cargando…

Contrast Sensitivity in Patients with Beta-Thalassemia Major and Sickle Cell Disease Under Regular Transfusions and Treatment with Desferrioxamine

PURPOSE: Evaluation of contrast sensitivity in patients with beta-thalassemia major and sickle cell disease which undergo regular transfusions and chelation therapy with desferrioxamine (DFX). MATERIALS AND METHODS: We studied contrast sensitivity in 48 eyes (24 patients) with beta-thalassemia major...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorezis, Spyridon, Asproudis, Ioannis, Chalasios, Nikolaos, Karali, Aikaterini, Tsanou, Elena, Peschos, Dimitrios, Christodoulou, Aikaterini, Aspiotis, Miltiadis
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944988/ https://www.ncbi.nlm.nih.gov/pubmed/20871749 http://dx.doi.org/10.2174/1874364101004010039

Ejemplares similares

Orbital cavernous hemangioma in an infant with intracranial lesions: a case report
por: Evagelidou, Eleni, et al.
Publicado: (2009)

Juvenile idiopathic arthritis-associated uveitis: Data from a region in western Greece
por: Asproudis, Ioannis, et al.
Publicado: (2010)

Protein Z Plasma Levels are Not Elevated in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy
por: Asproudis, Ioannis, et al.
Publicado: (2009)

Findings of an experimental study in a rabbit model on posterior capsule opacification after implantation of hydrophobic acrylic and hydrophilic acrylic intraocular lenses
por: Trakos, Nikolaos, et al.
Publicado: (2008)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011)

The role of sideport incision in astigmatism change after cataract surgery
por: Theodoulidou, Sofia, et al.
Publicado: (2015)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Case report of a neonate with ocular toxoplasmosis due to congenital infection: estimation of the percentage of ocular toxoplasmosis in Greece caused by congenital or acquired infection
por: Asproudis, Ioannis, et al.
Publicado: (2013)

An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use
por: Ward, Alexandra, et al.
Publicado: (2002)

Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan
por: Riaz, Haris, et al.
Publicado: (2011)

Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia
por: Fasano, R. M., et al.
Publicado: (2019)

Cardio-protective effect of regular transfusion in children with non-transfusion dependent thalassemia (NTDT): A cohort study
por: Al Senaidi, Khalfan, et al.
Publicado: (2022)

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion
por: Veríssimo, Monica Pinheiro de Almeida, et al.
Publicado: (2013)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Mucinous breast carcinoma presenting as Paget's disease of the nipple in a man: A case report
por: Peschos, Dimitrios, et al.
Publicado: (2008)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
por: de Montalembert, Mariane, et al.
Publicado: (2017)

Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience
por: Adramerina, Alkistis, et al.
Publicado: (2022)

Persistence of chronic inflammation after regular blood transfusion therapy in sickle cell anemia
por: Dembélé, Abdoul Karim, et al.
Publicado: (2022)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
por: Pepe, Alessia, et al.
Publicado: (2011)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

A prospective MRI study of left ventricular iron and function in non-trasfusion-dependent thalassemia intermedia patients treated with desferrioxamine
por: Meloni, Antonella, et al.
Publicado: (2015)

Successful Treatment of Acute Chest Syndrome with Manual Exchange Transfusion in a Patient with Sickle Beta(+)-thalassemia
por: Kawahara, Akihiro, et al.
Publicado: (2019)

P-083: IMPACT OF ALPHA THALASSEMIA COEXISTENCE ON TRANSFUSION NEED AMONG PATIENTS WITH SICKLE CELL DISEASE
por: A., MADRUGA DE OLIVEIRA LAGROTTA PITTELLA, et al.
Publicado: (2022)

5613475 ADVERSE REACTIONS TO RBC TRANSFUSION: A SINGLE THALASSEMIA AND SICKLE CELL DISEASE DEPARTMENT’S EXPERIENCE
por: Xydaki, A.X., et al.
Publicado: (2023)

Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
por: Kanavaki, Aikaterini, et al.
Publicado: (2017)

Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review
por: Caro, J Jaime, et al.
Publicado: (2002)

Desferrioxamine Reduces Oxidative Stress in the Lung Contusion
por: Basaran, Umit Nusret, et al.
Publicado: (2013)

5612535 THE IMPACT OF COVID19 PANDEMIC ON TRANSFUSION DEPENDENT -THALASSEMIA MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC TREATMENT CENTER
por: Maria Vousvouki, M.V., et al.
Publicado: (2023)

Squamous cell papilloma of the conjunctiva due to human papillomavirus (HPV): presentation of two cases and review of literature
por: Kalogeropoulos, Chris, et al.
Publicado: (2012)

Desferrioxamine decreases NAD redox potential of intact red blood cells: evidence for desferrioxamine as an inducer of oxidant stress in red blood cells
por: Niihara, Yutaka, et al.
Publicado: (2002)

Effect of quercetin on oxidative stress and liver function in beta-thalassemia major patients receiving desferrioxamine: A double-blind randomized clinical trial
por: Sajadi Hezaveh, Zohreh, et al.
Publicado: (2019)

Assessing Electroencephalography as a Stress Indicator: A VR High-Altitude Scenario Monitored through EEG and ECG
por: Aspiotis, Vasileios, et al.
Publicado: (2022)

Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center
por: Sorrentino, Francesco, et al.
Publicado: (2020)

Desferrioxamine-related ocular toxicity: A case report
por: Simon, Sumu, et al.
Publicado: (2012)

Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine
por: Savastano, Matteo, et al.
Publicado: (2019)

Pulmonary Functions in Transfusion-Dependent Thalassemia
por: Chandra, Jagdish, et al.
Publicado: (2022)

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE
por: de la Fuente, J., et al.
Publicado: (2023)

Choroidal Thickness Evaluation in a Transfusion-Dependent Beta-Thalassemia Greek Population
por: Tsapardoni, Foteini, et al.
Publicado: (2020)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1tea98d95v7k6ir1849rkjq9f3